Provided are an organic electroluminescent material and a device comprising the same. The organic electroluminescent material is a metal complex comprising a ligand L.sub.a having a structure of Formula 1A and a ligand L.sub.b having a structure of Formula 1B. Such new compounds each have a lower evaporation temperature, which is conducive to industrial application of the material and can reduce energy consumption in industrialization. Such metal complexes are used as a light-emitting material in an electroluminescent device. When applied to the electroluminescent device, such metal complexes can provide very excellent device performance, especially an improved device lifetime. Further provided are an organic electroluminescent device comprising the metal complex and a compound composition comprising the metal complex.

Provided are an organic electroluminescent material and a device comprising the same. The organic electroluminescent material is a metal complex comprising a ligand L.sub.a having a structure of Formula 1A and a ligand L.sub.b having a structure of Formula 1B. Such new compounds each have a lower evaporation temperature, which is conducive to industrial application of the material and can reduce energy consumption in industrialization. Such metal complexes are used as a light-emitting material in an electroluminescent device. When applied to the electroluminescent device, such metal complexes can provide very excellent device performance, especially an improved device lifetime. Further provided are an organic electroluminescent device comprising the metal complex and a compound composition comprising the metal complex.

Disclosed are a compound as represented by general formula (I), a cis-trans isomer thereof, an enantiomer thereof, a diastereoisomer thereof, a racemate thereof, a solvate thereof, a hydrate thereof, or a pharmaceutically acceptable salt thereof or a prodrug thereof, a preparation method therefor, a pharmaceutical composition comprising the compound and the use of the compound as an Lp-PLA.sub.2 inhibitor

##STR00001##

Disclosed are a compound as represented by general formula (I), a cis-trans isomer thereof, an enantiomer thereof, a diastereoisomer thereof, a racemate thereof, a solvate thereof, a hydrate thereof, or a pharmaceutically acceptable salt thereof or a prodrug thereof, a preparation method therefor, a pharmaceutical composition comprising the compound and the use of the compound as an Lp-PLA.sub.2 inhibitor

##STR00001##

The present invention provides novel triazatruxene derivatives that are useful as hole transport materials (HTM), particularly, in optoelectronic devices. The utility of the novel compounds was confirmed in solid-state, sensitized solar cells based on organic-inorganic perovskites used as light harvesters. The devices achieved high power conversion efficiencies.

The present invention provides novel triazatruxene derivatives that are useful as hole transport materials (HTM), particularly, in optoelectronic devices. The utility of the novel compounds was confirmed in solid-state, sensitized solar cells based on organic-inorganic perovskites used as light harvesters. The devices achieved high power conversion efficiencies.

A process for preparing pyrimido[4,5-g]pteridine-2,4,7,9-tetraol, or a salt thereof, is provided. A process for the preparation of 3,6-diaminopyrazine-2,5-dicarboxylic acid, or a salt thereof, from pyrimido[4,5-g]pteridine-2,4,7,9-tetraol, or a salt thereof, is further provided. A process for preparing a substituted pteridine compound, or a salt thereof, is further provided. A process for the preparation of a N-substituted 3,6-diaminopyrazine-2,5-dicarboxylic acid from a substituted pteridine compound, or a salt thereof, is further provided.

A process for preparing pyrimido[4,5-g]pteridine-2,4,7,9-tetraol, or a salt thereof, is provided. A process for the preparation of 3,6-diaminopyrazine-2,5-dicarboxylic acid, or a salt thereof, from pyrimido[4,5-g]pteridine-2,4,7,9-tetraol, or a salt thereof, is further provided. A process for preparing a substituted pteridine compound, or a salt thereof, is further provided. A process for the preparation of a N-substituted 3,6-diaminopyrazine-2,5-dicarboxylic acid from a substituted pteridine compound, or a salt thereof, is further provided.

Provided are novel organic molecules containing fused indole and benzimidazole moieties, or their boron containing analogs. Also provided are OLEDs and related consumer products that utilize these compounds containing the fused indole and benzimidazole moieties.

Provided are novel organic molecules containing fused indole and benzimidazole moieties, or their boron containing analogs. Also provided are OLEDs and related consumer products that utilize these compounds containing the fused indole and benzimidazole moieties.